Quantitative evaluation of fluorescein angiograms: microaneurysm counts

Area of Science:

• Ophthalmology
• Medical Imaging
• Biomedical Engineering

Background:

• Diabetic retinopathy diagnosis relies on detecting microaneurysms (MA) in fluorescein angiograms.
• Accurate and reproducible quantification of MA is crucial for monitoring disease progression and treatment efficacy.
• Existing methods may lack standardization, leading to variability in MA assessment.

Purpose of the Study:

• To introduce and validate a novel, reproducible method for quantifying microaneurysms (MA) from fluorescein angiograms.
• To assess the reliability of the MA quantification method through inter-observer and intra-observer variability studies.
• To determine the suitability of the developed method for application in clinical trials.

Main Methods:

• A standardized protocol was developed for identifying and counting microaneurysms (MA) on fluorescein angiograms.
• Reproducibility was assessed by having two independent observers read 30 angiograms twice each.
• Inter-observer and intra-observer differences in MA counts and precise MA locations were analyzed.

Main Results:

• The method demonstrated satisfactory reproducibility for MA quantification, with a correlation coefficient (r) greater than 0.9 between observers and readings.
• Reproducibility of MA location varied between 60% and 71%, influenced by angiogram quality.
• Clinicians and technicians across different centers achieved consistent results, indicating robustness.

Conclusions:

• The developed method for quantifying microaneurysms (MA) from fluorescein angiograms is highly reproducible and reliable.
• Its ease of learning and consistent performance make it suitable for large-scale clinical trials.
• This validated technique can enhance objective assessment and monitoring in ophthalmology research.